Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Procter & Gamble Health
₹6,277.50
+26.50 (0.42%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
6,237.00Prev. Close
6,251.00Volume
1,065Total traded value
0.67 CrUpper Circuit
7,501.00Lower Circuit
5,001.00Fundamentals
| Market Cap | ₹10,382Cr |
| ROE | 46.78% |
| P/E Ratio(TTM) | 34.54 |
| EPS(TTM) | 181.09 |
| P/B Ratio | 19.33 |
| Dividend Yield | 2.00% |
| Industry P/E | 41.14 |
| Book Value | 323.48 |
| Debt to Equity | 0.01 |
| Face Value | 10 |
Understand Fundamentals
Financials
About P&G Health
Procter & Gamble Health Limited is a leading Indian company manufacturing and marketing vitamins, minerals, and supplements, including well-known consumer brands like Neurobion and Evion. The company's core purpose is to provide branded products of superior quality and value that improve the lives of consumers around the world. It recently set a Guinness World Record with over 50,000 doctors pledging to diagnose and treat a common nerve condition.;
| Parent Organisation | Procter & Gamble Health Limited |
| Managing Director | Mr. Milind Thatte |
| NSE Symbol | PGHL |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 44.20 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 49.23 | ||
| Pfizer | NA (0.00%) | 28.68 | ||
| Astrazeneca Pharma India | NA (0.00%) | 120.77 |